Ibuprofen /d
PreclinicalSmall molecule
Ibuprofen /d is one of 5 small molecule programs targeting Acetaminophen. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
7 competitors in Acetaminophen
#DrugCompanyPhaseTrials
1Opioid
Johnson & JohnsonPhase 2
Vioxx
CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Preclinical
Acetominophen
Merck & Co.Preclinical
Aspirin Bid
UUniversity of Pennsylvania
Preclinical
Ibuprofen /d
UUniversity of Pennsylvania
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Ibuprofen /d. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversity of Pennsylvania